| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Edesa Biotech, Inc. (EDSA) has 9 insiders with recent SEC Form 4 filings, including 12 buys and 0 sells. EDSA is classified in the Biotechnology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| CEO | 501.8K | $2.79M | - | |
| Pres | 226.9K | $1.26M | - | |
| CFO | 65.0K | $360.8K | - | |
| Dir | 52.7K | $292.3K | - | |
| Dir | 30.4K | $168.8K | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Mar 30, 2022 | Nijhawan Pardeep | Chief Executive Officer | Buy | 2,000 | $3.05 | $6,098.20 | +0.4% | |
| Mar 29, 2022 | Nijhawan Pardeep | Chief Executive Officer | Buy | 2,000 | $3.02 | $6,033.60 | +0.4% | |
| Mar 18, 2022 | Nijhawan Pardeep | Chief Executive Officer | Buy | 2,000 | $3.85 | $7,699.20 | +0.4% | |
| Mar 17, 2022 | Nijhawan Pardeep | Chief Executive Officer | Buy | 2,000 | $3.26 | $6,522.36 | +0.2% | |
| Mar 15, 2022 | Nijhawan Pardeep | Chief Executive Officer | Buy | 2,000 | $2.80 | $5,598.00 | +0.4% | |
| Mar 14, 2022 | Brooks Michael J | President | Buy | 1,250 | $2.79 | $3,486.63 | +8.1% | |
| Mar 11, 2022 | Nijhawan Pardeep | Chief Executive Officer | Buy | 7,000 | $3.09 | $21,652.10 | +0.6% | |
| Mar 10, 2022 | Brooks Michael J | President | Buy | 1,000 | $3.22 | $3,222.90 | +6.9% | |
| Mar 9, 2022 | Nijhawan Pardeep | Chief Executive Officer | Buy | 1,500 | $3.05 | $4,569.60 | +0.3% | |
| Mar 8, 2022 | Brooks Michael J | President | Buy | 1,250 | $2.90 | $3,621.88 | +9.4% |